Zantac was originated by GSK and launched by the company in the early 1980s, which sold it as a prescription and over-the-counter (OTC) product for indications like heartburn and acid indigestion ...
Occupational studies stretching back decades have found an increased risk of bladder cancer among hairdressers.
The common claim in the lawsuits is that a contaminant in Zantac (ranitidine) called N-nitrosodimethylamine (NDMA) – as well as other ranitidine products – increased the risk of cancer.
While the Company repeatedly claimed that scientific research did not support a correlation between Zantac and cancer ... What Is The Lawsuit About? The complaint filed in this class action ...
Thousands of lawsuits against the manufacturers of AFFF have already been filed on behalf of military veterans, firefighters, and other individuals who have been diagnosed with cancer or other ...
Hailee Steinfeld and Wanda Sykes team up with pharmaceutical company Novartis to raise breast cancer awareness with a bold 2025 Super Bowl commercial. “It’s been on my bucket list to be in a ...
Feb 15 (Reuters) - Uber Technologies (UBER.N), opens new tab has filed a lawsuit against DoorDash(DASH.O), opens new tab, accusing the online delivery firm of anticompetitive practices ...
On Friday, OS Therapies, Inc. (NYSE-A: OSTX) entered into agreements for the commercial manufacture of OST-HER2. The company is currently organizing additional data about the recently completed ...
OS Therapies signed agreements for the commercial manufacture of OST-HER2 as it prepares for an FDA meeting and potential BLA submission. Phase 2b data show OST-HER2 significantly improved 12 ...
By Julia Jacobs The anonymous woman who accused Jay-Z and Sean Combs of raping her when she was 13 years old dropped her lawsuit on Friday against the hip-hop moguls. Jay-Z’s lawyers had pointed ...
WE’LL KEEP YOU UPDATED AS THIS PLAYS OUT. Pennsylvania Gov. Josh Shapiro has filed a lawsuit challenging President Donald Trump's federal funding freeze, calling it unconstitutional. Following ...